Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
Upgrades
升级
According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ:SEEL) was changed from Neutral to Buy. For the second quarter, Seelos Therapeutics had an EPS of $0.08, compared to year-ago quarter EPS of $0.08. The current stock performance of Seelos Therapeutics shows a 52-week-high of $6.60 and a 52-week-low of $0.56. Moreover, at the end of the last trading period, the closing price was at $2.09.
For Yandex NV (NASDAQ:YNDX), UBS upgraded the previous rating of Neutral to Buy. For the second quarter, Yandex had an EPS of $0.04, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $82.62 and a 52-week-low of $55.62. At the end of the last trading period, Yandex closed at $80.20.
SVB Leerink upgraded the previous rating for Sanofi SA (NASDAQ:SNY) from Market Perform to Outperform. Sanofi earned $1.66 in the second quarter, compared to $1.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $54.26 and a 52-week-low of $44.76. Sanofi closed at $47.94 at the end of the last trading period.
According to JMP Securities, the prior rating for Viant Technology Inc (NASDAQ:DSP) was changed from Market Perform to Market Outperform. Interestingly, in the second quarter, Viant Technology's EPS was $0.06. The current stock performance of Viant Technology shows a 52-week-high of $69.16 and a 52-week-low of $11.49. Moreover, at the end of the last trading period, the closing price was at $12.69.
JMP Securities upgraded the previous rating for Box Inc (NYSE:BOX) from Market Perform to Market Outperform. Box earned $0.21 in the second quarter, compared to $0.18 in the year-ago quarter. The current stock performance of Box shows a 52-week-high of $27.41 and a 52-week-low of $15.07. Moreover, at the end of the last trading period, the closing price was at $25.24.
Atlantic Equities upgraded the previous rating for Bath & Body Works Inc (NYSE:BBWI) from Neutral to Overweight. In the second quarter, Bath & Body Works earned $1.34.Bath & Body Works closed at $67.39 at the end of the last trading period.
For Icon PLC (NASDAQ:ICLR), JP Morgan upgraded the previous rating of Neutral to Overweight. For the second quarter, Icon had an EPS of $2.12, compared to year-ago quarter EPS of $1.20. At the moment, the stock has a 52-week-high of $284.20 and a 52-week-low of $168.76. Icon closed at $283.04 at the end of the last trading period.
For National Instruments Corp (NASDAQ:NATI), Goldman Sachs upgraded the previous rating of Neutral to Buy. For the second quarter, National Instruments had an EPS of $0.35, compared to year-ago quarter EPS of $0.26. At the moment, the stock has a 52-week-high of $47.40 and a 52-week-low of $30.42. National Instruments closed at $41.16 at the end of the last trading period.
根据Roth Capital的说法，之前的评级为Seelos治疗公司(纳斯达克市场代码：SEEL)从中性改为买入。第二季度，Seelos治疗公司的每股收益为0.08美元，而去年同期为0.08美元。Seelos Treeutics目前的股票表现显示，52周高点为6.60美元，52周低点为0.56美元。而且，在上个交易期结束时，收盘价为2.09美元。
为Yandex NV(Nasdaq：YNDX)，瑞银将此前中性评级上调至买入。第二季度，Yandex的每股收益为0.04美元，而去年同期为0.08美元。该股目前的52周高点为82.62美元，52周低点为55.62美元。上交易期尾盘，Yandex收报80.20美元。
SVB Leerink上调了之前的评级赛诺菲安万特(纳斯达克股票代码：SNY)从市场表现到强于大盘。赛诺菲第二季度盈利1.66美元，而去年同期为1.41美元。目前，该股的52周高点为54.26美元，52周低点为44.76美元。赛诺菲上交易期尾盘收报47.94美元。
根据JMP证券的说法，之前的评级为Viant Technology Inc.(纳斯达克市场代码：DSP)从市场表现改为市场表现好于市场。有趣的是，在第二季度，Viant Technology的每股收益为0.06美元。Viant Technology目前的股票表现显示，52周高点为69.16美元，52周低点为11.49美元。而且，在上个交易期结束时，收盘价为12.69美元。
JMP证券上调了之前对该公司的评级Box Inc.(纽约证券交易所股票代码：BOX)从市场表现到市场表现优异。Box第二季度盈利0.21美元，而去年同期为0.18美元。Box目前的股票表现显示，52周高点为27.41美元，52周低点为15.07美元。而且，在上个交易期结束时，收盘价为25.24美元。
大西洋证券公司上调了之前的评级，Bath&Body Works Inc.(纽约证券交易所股票代码：BBWI)从中性到超重。在第二季度，Bath&Body Works赚了1.34美元，Bath&Body Works在上个交易期结束时收于67.39美元。
为图标PLC(纳斯达克股票代码：ICLR)，摩根大通将之前的中性评级上调至加码。第二季度，Icon的每股收益为2.12美元，而去年同期为1.20美元。目前，该股的52周高点为284.20美元，52周低点为168.76美元。ICON上交易日尾盘报283.04美元。
为美国国家仪器公司(National Instruments Corp)(纳斯达克股票代码：Nati)，高盛将之前中性的评级上调至买入。第二季度，National Instruments的每股收益为0.35美元，而去年同期为0.26美元。目前，该股的52周高点为47.40美元，52周低点为30.42美元。National Instruments上一交易期尾盘报41.16美元。
See all analyst ratings upgrades.
查看所有分析师评级升级。
Downgrades
降级
According to Credit Suisse, the prior rating for Altice USA Inc (NYSE:ATUS) was changed from Outperform to Neutral. In the second quarter, Altice USA showed an EPS of $0.51, compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $38.30 and a 52-week-low of $19.74. Altice USA closed at $20.58 at the end of the last trading period.
B of A Securities downgraded the previous rating for Hyatt Hotels Corp (NYSE:H) from Neutral to Underperform. Hyatt Hotels earned $1.15 in the second quarter, compared to $1.80 in the year-ago quarter. The current stock performance of Hyatt Hotels shows a 52-week-high of $92.22 and a 52-week-low of $51.21. Moreover, at the end of the last trading period, the closing price was at $79.76.
For American Water Works Co Inc (NYSE:AWK), B of A Securities downgraded the previous rating of Neutral to Underperform. American Water Works Co earned $1.14 in the second quarter, compared to $0.97 in the year-ago quarter. The current stock performance of American Water Works Co shows a 52-week-high of $189.35 and a 52-week-low of $131.01. Moreover, at the end of the last trading period, the closing price was at $176.79.
JP Morgan downgraded the previous rating for Talis Biomedical Corp (NASDAQ:TLIS) from Neutral to Underweight. Interestingly, in the second quarter, Talis Biomedical's EPS was $2.51. The stock has a 52-week-high of $33.90 and a 52-week-low of $6.81. At the end of the last trading period, Talis Biomedical closed at $7.04.
For Zymergen Inc (NASDAQ:ZY), JP Morgan downgraded the previous rating of Neutral to Underweight. Interestingly, in the second quarter, Zymergen's EPS was $1.30. The current stock performance of Zymergen shows a 52-week-high of $52.00 and a 52-week-low of $7.85. Moreover, at the end of the last trading period, the closing price was at $13.40.
According to Goldman Sachs, the prior rating for Lordstown Motors Corp (NASDAQ:RIDE) was changed from Neutral to Sell. In the second quarter, Lordstown Motors showed an EPS of $0.61, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $31.57 and a 52-week-low of $4.77. At the end of the last trading period, Lordstown Motors closed at $7.57.
Raymond James downgraded the previous rating for Altice USA Inc (NYSE:ATUS) from Outperform to Market Perform. For the second quarter, Altice USA had an EPS of $0.51, compared to year-ago quarter EPS of $0.19. At the moment, the stock has a 52-week-high of $38.30 and a 52-week-low of $19.74. Altice USA closed at $20.58 at the end of the last trading period.
根据瑞士信贷(Credit Suisse)的说法，之前的评级为Altice USA Inc.(纽约证券交易所代码：ATUS)从强于大盘改为中性。第二季度，Altice USA的每股收益为0.51美元，而去年同期为0.19美元。目前，该股的52周高点为38.30美元，52周低点为19.74美元。Altice USA上交易日尾盘报20.58美元。
B of A Securities下调之前的评级为凯悦酒店集团(纽约证券交易所股票代码：H)从中性到表现不佳。凯悦酒店第二季度盈利1.15美元，而去年同期为1.80美元。凯悦酒店目前的股票表现显示52周高点92.22美元和52周低点51.21美元。而且，在上个交易期结束时，收盘价为79.76美元。
为美国水务公司(纽约证券交易所代码：AWK)，B of A Securities将此前评级下调至中性至表现不佳。美国水务公司(American Water Works Co)第二季度盈利1.14美元，而去年同期为0.97美元。美国水务公司(American Water Works Co)目前的股票表现显示，52周高点为189.35美元，52周低点为131.01美元。而且，在上个交易期结束时，收盘价为176.79美元。
摩根大通下调了之前的评级为塔利斯生物医学公司(纳斯达克股票代码：TLIS)从中性到减持。有趣的是，在第二季度，Talis Biomedical的每股收益为2.51美元。该股目前的52周高点为33.90美元，52周低点为6.81美元。上交易期尾盘，Talis Biomedical收报7.04美元。
为Zymergen Inc.(纳斯达克股票代码：ZY)，摩根大通将之前的评级下调至中性至减持。有趣的是，在第二季度，Zymergen的每股收益为1.30美元。Zymergen目前的股票表现显示，52周高点为52.00美元，52周低点为7.85美元。而且，在上个交易期结束时，收盘价为13.40美元。
根据高盛(Goldman Sachs)的说法，之前的评级为洛德斯敦汽车公司(Lordstown Motors Corp)(纳斯达克股票代码：RIDE)从中性改为卖出。第二季度，Lordstown Motors的每股收益为0.61美元，而去年同期为0.11美元。该股目前的52周高点为31.57美元，52周低点为4.77美元。上一交易期尾盘，Lordstown Motors收报7.57美元。
雷蒙德·詹姆斯(Raymond James)下调了之前的评级Altice USA Inc.(纽约证券交易所股票代码：ATUS)从强于大盘到市场表现。第二季度，Altice USA的每股收益为0.51美元，而去年同期为0.19美元。目前，该股的52周高点为38.30美元，52周低点为19.74美元。Altice USA上交易日尾盘报20.58美元。
See all analyst ratings downgrades.
查看所有分析师评级下调。
Initiations
启蒙行动
With a Hold rating, Vertical Research initiated coverage on Ecolab Inc (NYSE:ECL). The price target seems to have been set at $189.00 for Ecolab. In the second quarter, Ecolab showed an EPS of $1.22, compared to $0.65 from the year-ago quarter. The current stock performance of Ecolab shows a 52-week-high of $231.25 and a 52-week-low of $181.25. Moreover, at the end of the last trading period, the closing price was at $223.77.
With a Buy rating, Craig-Hallum initiated coverage on dMY Technology Group Inc IV (NYSE:DMYQ). The price target seems to have been set at $15.00 for dMY Technology Group Inc. The current stock performance of dMY Technology Group Inc shows a 52-week-high of $10.48 and a 52-week-low of $9.57. Moreover, at the end of the last trading period, the closing price was at $9.95.
With a Buy rating, Maxim Group initiated coverage on SPI Energy Co Ltd (NASDAQ:SPI). The price target seems to have been set at $12.00 for SPI Energy. At the moment, the stock has a 52-week-high of $28.71 and a 52-week-low of $4.59. SPI Energy closed at $5.36 at the end of the last trading period.
With a Buy rating, Canaccord Genuity initiated coverage on Pacific Biosciences of California Inc (NASDAQ:PACB). The price target seems to have been set at $45.00 for Pacific Biosciences. In the second quarter, Pacific Biosciences showed an EPS of $0.21, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $53.69 and a 52-week-low of $8.05. At the end of the last trading period, Pacific Biosciences closed at $25.58.
Cantor Fitzgerald initiated coverage on Sierra Oncology Inc (NASDAQ:SRRA) with an Overweight rating. The price target for Sierra Oncology is set to $33.00. For the second quarter, Sierra Oncology had an EPS of $1.41, compared to year-ago quarter EPS of $1.58. The current stock performance of Sierra Oncology shows a 52-week-high of $23.85 and a 52-week-low of $10.02. Moreover, at the end of the last trading period, the closing price was at $22.45.
With an Outperform rating, SVB Leerink initiated coverage on UnitedHealth Group Inc (NYSE:UNH). The price target seems to have been set at $480.00 for UnitedHealth Group. In the second quarter, UnitedHealth Group showed an EPS of $4.70, compared to $7.12 from the year-ago quarter. The stock has a 52-week-high of $431.36 and a 52-week-low of $289.64. At the end of the last trading period, UnitedHealth Group closed at $407.08.
SVB Leerink initiated coverage on Mednax Inc (NYSE:MD) with a Market Perform rating. The price target for Mednax is set to $29.00. Mednax earned $0.41 in the second quarter, compared to $0.32 in the year-ago quarter. The current stock performance of Mednax shows a 52-week-high of $35.67 and a 52-week-low of $12.47. Moreover, at the end of the last trading period, the closing price was at $28.85.
With a Market Perform rating, Keefe, Bruyette & Woods initiated coverage on Jackson Financial Inc (NYSE:JXN). The price target seems to have been set at $30.00 for Jackson Financial. In the second quarter, Jackson Financial earned $6.74. Jackson Financial closed at $27.90 at the end of the last trading period.
SVB Leerink initiated coverage on AdaptHealth Corp (NASDAQ:AHCO) with an Outperform rating. The price target for AdaptHealth is set to $30.00. For the second quarter, AdaptHealth had an EPS of $0.17, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $41.58 and a 52-week-low of $19.17. AdaptHealth closed at $23.00 at the end of the last trading period.
SVB Leerink initiated coverage on Acadia Healthcare Co Inc (NASDAQ:ACHC) with an Outperform rating. The price target for Acadia Healthcare Co is set to $85.00. In the second quarter, Acadia Healthcare Co showed an EPS of $0.71, compared to $0.54 from the year-ago quarter. The current stock performance of Acadia Healthcare Co shows a 52-week-high of $68.65 and a 52-week-low of $27.07. Moreover, at the end of the last trading period, the closing price was at $65.15.
SVB Leerink initiated coverage on Tenet Healthcare Corp (NYSE:THC) with a Market Perform rating. The price target for Tenet Healthcare is set to $80.00. For the second quarter, Tenet Healthcare had an EPS of $1.59, compared to year-ago quarter EPS of $1.26. At the moment, the stock has a 52-week-high of $76.16 and a 52-week-low of $21.34. Tenet Healthcare closed at $71.39 at the end of the last trading period.
SVB Leerink initiated coverage on Humana Inc (NYSE:HUM) with an Outperform rating. The price target for Humana is set to $494.00. Humana earned $6.89 in the second quarter, compared to $12.56 in the year-ago quarter. The current stock performance of Humana shows a 52-week-high of $475.44 and a 52-week-low of $370.22. Moreover, at the end of the last trading period, the closing price was at $398.91.
SVB Leerink initiated coverage on Cigna Corp (NYSE:CI) with a Market Perform rating. The price target for Cigna is set to $220.00. For the second quarter, Cigna had an EPS of $5.24, compared to year-ago quarter EPS of $5.81. The stock has a 52-week-high of $272.81 and a 52-week-low of $158.84. At the end of the last trading period, Cigna closed at $203.89.
SVB Leerink initiated coverage on Amedisys Inc (NASDAQ:AMED) with a Market Perform rating. The price target for Amedisys is set to $170.00. For the second quarter, Amedisys had an EPS of $1.69, compared to year-ago quarter EPS of $1.34. The stock has a 52-week-high of $325.12 and a 52-week-low of $154.52. At the end of the last trading period, Amedisys closed at $155.35.
SVB Leerink initiated coverage on HCA Healthcare Inc (NYSE:HCA) with an Outperform rating. The price target for HCA Healthcare is set to $320.00. In the second quarter, HCA Healthcare showed an EPS of $4.37, compared to $3.23 from the year-ago quarter. The stock has a 52-week-high of $263.92 and a 52-week-low of $114.38. At the end of the last trading period, HCA Healthcare closed at $256.33.
With a Market Perform rating, SVB Leerink initiated coverage on Anthem Inc (NYSE:ANTM). The price target seems to have been set at $403.00 for Anthem. For the second quarter, Anthem had an EPS of $7.03, compared to year-ago quarter EPS of $9.20. The current stock performance of Anthem shows a 52-week-high of $406.00 and a 52-week-low of $244.10. Moreover, at the end of the last trading period, the closing price was at $381.33.
With an Outperform rating, SVB Leerink initiated coverage on Agilon Health Inc (NYSE:AGL). The price target seems to have been set at $37.00 for Agilon Health. Agilon Health earned $0.79 in the second quarter. At the moment, the stock has a 52-week-high of $44.83 and a 52-week-low of $26.50. Agilon Health closed at $28.10 at the end of the last trading period.
JP Morgan initiated coverage on Omeros Corp (NASDAQ:OMER) with a Neutral rating. The price target for Omeros is set to $15.00. Omeros earned $0.46 in the second quarter, compared to $0.61 in the year-ago quarter. The current stock performance of Omeros shows a 52-week-high of $23.85 and a 52-week-low of $9.25. Moreover, at the end of the last trading period, the closing price was at $15.88.
With a Buy rating, Jefferies initiated coverage on Kinnate Biopharma Inc (NASDAQ:KNTE). The price target seems to have been set at $46.00 for Kinnate Biopharma. Kinnate Biopharma earned $0.49 in the second quarter, compared to $2.05 in the year-ago quarter. The current stock performance of Kinnate Biopharma shows a 52-week-high of $48.75 and a 52-week-low of $17.58. Moreover, at the end of the last trading period, the closing price was at $22.67.
With a Neutral rating, JP Morgan initiated coverage on Airbnb Inc (NASDAQ:ABNB). The price target seems to have been set at $170.00 for Airbnb. For the second quarter, Airbnb had an EPS of $0.11, compared to year-ago quarter EPS of $1.30. The current stock performance of Airbnb shows a 52-week-high of $219.94 and a 52-week-low of $121.50. Moreover, at the end of the last trading period, the closing price was at $175.88.
在持有评级的情况下，Vertical Research启动了对Ecolab Inc.(纽约证券交易所代码：ECL)。Ecolab的目标价似乎被设定在189.00美元。第二季度，Ecolab显示每股收益为1.22美元，而去年同期为0.65美元。Ecolab目前的股票表现显示，52周高点为231.25美元，52周低点为181.25美元。而且，在上个交易期结束时，收盘价为223.77美元。
凭借买入评级，Craig-Hallum在DMY科技集团公司IV(纽约证券交易所代码：DMYQ)。DMY科技集团(DMY Technology Group Inc)的目标价似乎被设定在15.00美元。目前DMY科技集团(DMY Technology Group Inc)的股价表现显示，其股价创下52周高位10.48美元和52周低点9.57美元。而且，在上个交易期结束时，收盘价为9.95美元。
凭借买入评级，Maxim Group在阳光动力(纳斯达克市场代码：SPI)。SPI Energy的目标价似乎被设定在12.00美元。目前，该股的52周高点为28.71美元，52周低点为4.59美元。SPI Energy上一交易期尾盘报5.36美元。
凭借买入评级，Canaccel Genuity在加州太平洋生物科学公司(纳斯达克股票代码：PACB)太平洋生物科学公司的目标价格似乎被设定在45.00美元。太平洋生物科学公司第二季度的每股收益为0.21美元，而去年同期为0.15美元。该股52周高点为53.69美元，52周低点为8.05美元。太平洋生物科学上交易期尾盘收报25.58美元。
康托·菲茨杰拉德(Cantor Fitzgerald)在塞拉肿瘤公司(纳斯达克股票代码：SRRA)，评级为增持。Sierra Oncology的目标价格定为33.00美元。第二季度，Sierra Oncology的每股收益为1.41美元，而去年同期为1.58美元。Sierra Oncology目前的股票表现显示，52周高点为23.85美元，52周低点为10.02美元。而且，在上个交易期结束时，收盘价为22.45美元。
凭借强于大盘的评级，SVB Leerink在联合健康(纽约证券交易所市场代码：UNH)。UnitedHealth Group的目标价格似乎被设定在480.00美元。UnitedHealth Group第二季度每股收益为4.70美元，而去年同期为7.12美元。该股目前的52周高点为431.36美元，52周低点为289.64美元。上一交易期尾盘，联合健康集团收报407.08美元。
SVB Leerink在MEDNAX公司(纽约证券交易所股票代码：MD)具有市场表现评级。Mednax的目标价定为29.00美元。MEDNAX第二季度盈利0.41美元，而去年同期为0.32美元。Mednax目前的股票表现显示，52周高点为35.67美元，52周低点为12.47美元。而且，在上个交易期结束时，收盘价为28.85美元。
凭借市场表现评级，Keefe，Bruyette&Woods在杰克逊金融公司(纽约证券交易所代码：JXN)。杰克逊金融公司的目标价似乎被设定在30.00美元。在第二季度，杰克逊金融公司赚了6.74美元。Jackson Financial上一交易期尾盘报27.90美元。
SVB Leerink在AdaptHealth公司(纳斯达克股票代码：AHCO)，评级优于大盘。AdaptHealth的目标价设为30.00美元。第二季度，AdaptHealth的每股收益为0.17美元，而去年同期为0.08美元。目前，该股的52周高点为41.58美元，52周低点为19.17美元。AdaptHealth上交易期尾盘收报23.00美元。
SVB Leerink在阿卡迪亚医疗保健公司(Acadia Healthcare Co Inc.)(纳斯达克股票代码：ACHC)，评级为跑赢大盘。阿卡迪亚医疗保健公司(Acadia Healthcare Co)的目标价定为85.00美元。阿卡迪亚医疗保健公司(Acadia Healthcare Co)第二季度每股收益为0.71美元，而去年同期为0.54美元。阿卡迪亚医疗保健公司(Acadia Healthcare Co)目前的股票表现显示，其股价为68.65美元的52周高位和27.07美元的52周低点。而且，在上个交易期结束时，收盘价为65.15美元。
SVB Leerink在Tenet Healthcare Corp(纽约证券交易所股票代码：THC)，市场表现评级。Tenet Healthcare的目标价定为80.00美元。第二季度，Tenet Healthcare的每股收益为1.59美元，而去年同期为1.26美元。目前，该股的52周高点为76.16美元，52周低点为21.34美元。Tenet Healthcare上交易日尾盘收报71.39美元。
SVB Leerink在Humana Inc.(纽约证券交易所股票代码：HUM)，评级优于大盘。Humana的目标价定为494.00美元。Humana第二季度的利润为6.89美元，而去年同期为12.56美元。Humana目前的股票表现显示，52周高点为475.44美元，52周低点为370.22美元。而且，在上个交易期结束时，收盘价为398.91美元。
SVB Leerink在信诺(纽约证券交易所股票代码：CI)具有市场表现评级。信诺的目标价定为220.00美元。信诺第二季度每股收益为5.24美元，而去年同期为5.81美元。该股目前的52周高点为272.81美元，52周低点为158.84美元。上交易期尾盘，信诺收报203.89美元。
SVB Leerink在Amedisys Inc.(纳斯达克股票代码：AMED)，市场表现评级。美国运通的目标价定为170.00美元。第二季度，Amedisys的每股收益为1.69美元，而去年同期为1.34美元。该股目前的52周高点为325.12美元，52周低点为154.52美元。上一交易期尾盘，美国运通收报155.35美元。
SVB Leerink在HCA控股(纽约证券交易所股票代码：HCA)，评级优于大盘。HCA Healthcare的目标价格定为320.00美元。第二季度，HCA Healthcare显示每股收益为4.37美元，而去年同期为3.23美元。该股目前的52周高点为263.92美元，52周低点为114.38美元。上交易期尾盘，HCA Healthcare收报256.33美元。
凭借市场表现评级，SVB Leerink在Anthem(纽约证券交易所代码：ANTM)。国歌的目标价格似乎被设定在403.00美元。第二季度，国歌的每股收益为7.03美元，而去年同期为9.20美元。国歌目前的股票表现显示，52周高点为406.00美元，52周低点为244.10美元。而且，在上个交易期结束时，收盘价为381.33美元。
凭借强于大盘的评级，SVB Leerink在安捷伦健康公司(Agilon Health Inc.)(纽约证券交易所代码：AGL)。安捷伦健康的目标价格似乎被设定在37.00美元。安捷伦健康第二季度盈利0.79美元。目前，该股的52周高点为44.83美元，52周低点为26.50美元。安捷伦健康上交易期尾盘收报28.10美元。
摩根大通在Omeros公司(纳斯达克股票代码：OMER)评级为中性。Omeros的目标价定为15.00美元。Omeros第二季度盈利0.46美元，而去年同期为0.61美元。目前Omeros的股票表现显示，52周高点为23.85美元，52周低点为9.25美元。而且，在上个交易期结束时，收盘价为15.88美元。
在获得买入评级的情况下，Jefferies在Kinnate Biophma Inc.(纳斯达克市场代码：KNTE)Kinnate Biophma的目标价似乎被设定在46.00美元。Kinnate Biophma第二季度盈利0.49美元，而去年同期为2.05美元。Kinnate Biophma目前的股票表现显示，52周高点为48.75美元，52周低点为17.58美元。而且，在上个交易期结束时，收盘价为22.67美元。
评级为中性，摩根大通在爱彼迎股份有限公司(纳斯达克股票代码：ABNB)爱彼迎的目标价似乎被设定在170.00美元。第二季度，爱彼迎的每股收益为0.11美元，而去年同期为1.3美元。爱彼迎目前的股票表现显示，52周高点为219.94美元，52周低点为121.50美元。而且，在上个交易期结束时，收盘价为175.88美元。
See all analyst ratings initiations.
查看所有分析师评级启动。